ALUR

Allurion Technologies, Inc. · NYSE

Sector Health Technology
Industry Medical Specialties
Website allurion.com
Employees(FY) 268
ISIN US02008G1022

Performance

-16.9%

1W

-25.0%

1M

-37.01%

3M

-58.35%

6M

-52.67%

YTD

-83.06%

1Y

Profile

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Advanced Technical Analysis

Technical Analysis of ALUR 2024-05-10

Overview:

In analyzing the technical indicators for ALUR over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive view of the stock's potential price movement. By examining these key factors, we aim to offer insights and predictions for the next few days.

Trend Analysis:

Moving A...

See more ...

Recent News & Updates

2024-05-14 20:00
Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss(Businesswire)
2024-05-14 00:53
ALUR Stock Earnings: Allurion Technologies Beats EPS, Beats Revenue for Q1 2024(Investorplace)
2024-05-13 20:00
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update(Businesswire)
2024-05-01 20:00
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey(Businesswire)
2024-04-29 20:30
Allurion Announces Preliminary First Quarter 2024 Results(Businesswire)
2024-04-16 20:31
Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments(Businesswire)
2024-04-03 20:00
Allurion Expands Virtual Care Suite to the United States(Businesswire)
2024-03-21 00:53
ALUR Stock Earnings: Allurion Technologies Beats EPS, Beats Revenue for Q4 2023(Investorplace)
2024-03-20 20:00
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance(Businesswire)
2024-03-12 20:30
Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference(Businesswire)
2024-03-11 20:00
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair(Businesswire)
2024-03-03 19:30
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024(Businesswire)
2024-02-20 03:05
Allurion to Participate in Cowens 44th Annual Health Care Conference(Businesswire)
2024-02-07 19:30
Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference(Businesswire)
2024-01-28 19:00
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies(Businesswire)
2024-01-22 20:04
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss(Yahoo Finance)
2024-01-22 19:15
World first : Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss(Businesswire)
2024-01-16 19:00
Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships(Businesswire)
2024-01-10 19:00
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities(Businesswire)
2024-01-07 19:00
Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook(Businesswire)
2024-01-04 19:00
New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program(Businesswire)
2024-01-01 19:00
Allurions Digital Platform Gains Traction with Expanded Strategic Partnership(Businesswire)
2023-11-12 19:00
Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update(Businesswire)
2023-11-06 03:05
Allurion to Participate in the Jefferies London Healthcare Conference(Businesswire)
2023-11-05 19:00
Allurion to Report Third Quarter 2023 Financial Results on November 13, 2023(Businesswire)
2023-10-10 20:00
Allurion Completes Enrollment in Pivotal AUDACITY Trial for the Allurion Balloon(Businesswire)
2023-10-03 20:00
Allurion Announces Acceptance of Five Abstracts for Presentation at Obesity Week 2023(Businesswire)
2023-09-17 20:00
Allurion Featured at the 2023 International Bariatric Club Oxford University World Congress(Yahoo Finance)
2023-08-28 20:00
Allurion Introduces Coach Iris: A 24/7 Generative AI-Powered Weight Loss Coach(Yahoo Finance)
2023-08-27 20:00
Allurion Announces Acceptance of Nine Scientific Presentations at IFSO 2023 World Congress(Yahoo Finance)

Page 1 of 2

previousnext